Doctors

Professor Zhou Zejian specializes in minimally invasive interventional and comprehensive treatment for malignant and non-malignant diseases, including arterial stenosis and occlusion, venous stenosis and occlusion, hemangioma, vascular malformation, varicocele, uterine fibroids, diabetic foot, cysts, abscesses, etc. Professor Zhou and his team perform nearly ten thousand operations annually. A large number of patients have survived for more than 10 years after surgery, and some have survived for 20 to 30 years.

Specialties: Internal medicine systematic treatments such as chemotherapy, endocrine therapy, targeted therapy, and immunotherapy for various malignant tumors, especially lung cancer, gastrointestinal tumors, breast cancer, head and neck, and genitourinary system tumors, and multi-disciplinary comprehensive treatment of complex malignant tumors combining individualized precise treatment with surgery, radiotherapy, intervention, hyperthermia, and iodine-125 seed implantation.

Professor Chen Tao specializes in the precise diagnosis and comprehensive treatment of hematological malignancies (such as leukemia, lymphoma, and multiple myeloma) and various solid tumors, with particular expertise in the following areas:Cancer Immunotherapy: Proficient in the personalized application of advanced immunotherapies, including cellular immunotherapy, immune checkpoint inhibitors, and therapeutic cancer vaccines.Multimodal Integrated Therapy: Skilled in innovatively integrating immunotherapy with traditional approaches such as chemotherapy, targeted therapy, and radiotherapy, developing optimal sequential or combination treatment plans for patients.Management of Complex and Severe Cases: Specializes in treating relapsed or refractory hematological lymphomas and metastatic solid tumors, providing internationally aligned treatment solutions.Precise Immune Function Assessment: Utilizes advanced testing systems to comprehensively evaluate patients' immune status, establishing a scientific foundation for precise immunotherapy.

Vascular Interventional Therapy: Highly skilled and experienced in vascular interventional treatments for systemic tumors, including hepatocellular carcinoma, lung cancer, head and neck tumors, gastrointestinal tumors, cervical cancer, breast cancer, prostate cancer, soft tissue malignancies, hemangiomas, and pediatric tumors. Comprehensive Complication Management: Possesses unique insights and substantial clinical experience in managing malignant pleural and peritoneal effusions, as well as preventing and treating various post-interventional complications.Non-vascular Interventional Techniques: Proficient in a range of non-vascular interventional procedures, including tumor ablation, radioactive seed implantation, esophageal stent placement, percutaneous gastrostomy, and various precision puncture techniques.

Specializes in the application of traditional Chinese medicine combined with modern medicine in interventional radiology, tumor hyperthermia, and physical therapy. He is skilled in using minimally invasive interventional techniques to achieve precise treatment of intermediate and advanced malignant tumors such as liver cancer, lung cancer, nasopharyngeal carcinoma, gastric cancer, colorectal cancer, esophageal cancer, breast cancer, and pancreatic cancer. He has rich clinical experience and practical results in the application of radioactive seed therapy for soft tissue tumors, residual postoperative cancer, and patients with unresectable tumors.

Co‑inventor of Luo Pengfei Programmed Oncology Diagnosis and Treatment (protected by international patent). Based on the principle that tumor biological activity can be inactivated, he applies a three‑step anti‑tumor strategy: tumor control, tumor shrinkage, and tumor inactivation, using programmed minimally invasive techniques for the treatment of malignant tumors.He comprehensively applies various minimally invasive techniques including superselective arterial chemoembolization, radioactive seed implantation, physical ablation, and vascular, esophageal and biliary stent implantation for neoplastic and non‑neoplastic diseases: Arterial infusion and embolization for solid tumors including liver cancer, lung cancer, renal cancer, bladder cancer, gynecological and head & neck tumors. Local ablation for malignant tumors: microwave, radiofrequency, and argon‑helium cryoablation. ¹²⁵I radioactive seed implantation for malignant tumors. Vertebroplasty for vertebral compression fractures. Embolization for uterine fibroids and hepatic hemangiomas. Metallic stent placement for vascular, esophageal and biliary strictures caused by tumor compression. Emergency embolization for massive hemoptysis, traumatic liver/kidney rupture, gastrointestinal bleeding, postpartum hemorrhage and other acute bleeding. Chemotherapy, targeted therapy and immunotherapy for solid tumors. Transjugular intrahepatic portosystemic shunt (TIPS) for liver cirrhosis, catheter drainage for intestinal obstruction, etc.

Proficient in the diagnosis, treatment and surgery of common general surgical diseases involving the hepatobiliary, splenic and pancreatic systems, thyroid and breast hernias, and the gastrointestinal tract. He has profound expertise in the comprehensive treatment of thyroid tumors, breast tumors, gastric cancer, colorectal cancer, rectal cancer, liver cancer, cholangiocarcinoma, and pancreatic cancer.

Precision treatment of various advanced malignancies, with distinctive insights in recurrent and metastatic cancers and complex cases such as lung cancer, liver cancer, breast cancer, colorectal cancer, gastric cancer, cervical cancer, sarcoma, and head and neck tumors.

Diagnosis and minimally invasive treatment of liver cancer and lung cancer;Minimally invasive treatment of uterine fibroids and adenomyosis;Endovascular thrombectomy for deep vein thrombosis and pulmonary embolism;Endovascular embolization for various acute hemorrhages;Treatment of lower extremity arterial occlusive disease. He specializes in interventional therapy for various solid tumors, including radioactive seed implantation, microwave ablation, and other tumor and vascular interventional procedures.

Radiotherapy for thoracic tumors (lung cancer, thymic cancer, esophageal cancer), nasopharyngeal carcinoma, etc.Comprehensive treatment of lung cancer; chemoradiotherapy for intermediate and advanced nasopharyngeal carcinoma. She provides individualized comprehensive treatment for intermediate and advanced lung cancer, esophageal cancer, breast cancer and nasopharyngeal carcinoma, including radiotherapy, chemotherapy, targeted therapy and immunotherapy.She also has unique expertise in managing side effects and sequelae caused by tumor radiotherapy and chemotherapy.

Treatment of liver cancer and liver cirrhosis using various minimally invasive techniques, including iodine-125 seed implantation, interventional therapy, microwave and radiofrequency ablation, biological therapy, and liver transplantation for liver cancer.

His primary research focus is the diagnosis and treatment of head and neck tumors. Renowned as a “zero‑bleeding” expert, he developed the innovative “intermittent blocking ligation method” and “mattress continuous cross‑suture technique,” which effectively prevent and reduce intraoperative bleeding. He has achieved remarkable results in surgeries for thyroid tumors, parotid tumors, and orofacial and cervical hemangiomas, and has trained numerous outstanding medical professionals throughout his career.

He has extensive clinical experience in the diagnosis and treatment of various malignancies, with particular expertise in leukemia, lymphoma, multiple myeloma, MDS (myelodysplastic syndrome), and difficult/metastatic lung cancer. He also has strong proficiency in the management of nasopharyngeal carcinoma, gastrointestinal cancer, breast cancer, and sarcoma.

With over 40 years of clinical experience in the diagnosis and treatment of solid tumors such as liver cancer, lung cancer, pancreatic cancer, cholangiocellular carcinoma, head and neck cancer, bone metastases, and colorectal cancer with liver metastases. He is the founder of the "Luo Pengfei Programmed Tumor Diagnosis and Treatment Method", which is protected by an international patent. Based on the assertion that the biological activity of tumors can be inactivated, he adopts a three-step anti-cancer approach (tumor control, tumor shrinkage, and tumor inactivation) in clinical practice to perform programmed minimally invasive treatment of malignant tumors targeting the inactivation of tumor biological activity.